Cytokine & Growth Factor Reviews

Papers
(The median citation count of Cytokine & Growth Factor Reviews is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Editorial Board140
Unveiling cytokine charge disparity as a potential mechanism for immune regulation136
Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions116
Macrophage-derived cytokines in pneumonia: Linking cellular immunology and genetics109
COVID-19 as a mediator of interferon deficiency and hyperinflammation: Rationale for the use of JAK1/2 inhibitors in combination with interferon105
Potential effects of HMGB1 on viral replication and virus infection-induced inflammatory responses: A promising therapeutic target for virus infection-induced inflammatory diseases93
Navigating IL-6: From molecular mechanisms to therapeutic breakthroughs89
COVID-19: From emerging variants to vaccination77
Editorial Board72
Editorial Board71
Editorial Board68
Proteomics analysis of circulating small extracellular vesicles: Focus on the contribution of EVs to tumor metabolism65
Insights into IL-6/JAK/STAT3 signaling in the tumor microenvironment: Implications for cancer therapy64
Participation of interferons in psoriatic inflammation62
CDK4/6 inhibition in hormone receptor-positive/HER2-negative breast cancer: Biological and clinical aspects62
Progranulinopathy: A diverse realm of disorders linked to progranulin imbalances61
Gradients in the in vivo intestinal stem cell compartment and their in vitro recapitulation in mimetic platforms58
Molecular mechanisms of regulation of IL-1 and its receptors57
Epithelial-to-mesenchymal transition transcription factors: New strategies for mesenchymal tissue regeneration54
Immuno-metabolic control of the balance between Th17-polarized and regulatory T-cells during HIV infection51
The immunosuppressive and pro-tumor functions of CCL18 at the tumor microenvironment50
Central role of Galectin-3 at the cross-roads of cardiac inflammation and fibrosis: Implications for heart failure and transplantation49
Novel insights into neuroinflammatory mechanisms in traumatic brain injury: Focus on pattern recognition receptors as therapeutic targets48
Pro-angiogenic activity and vasculogenic mimicry in the tumor microenvironment by leptin in cancer47
Asprosin, a novel pleiotropic adipokine implicated in fasting and obesity-related cardio-metabolic disease: Comprehensive review of preclinical and clinical evidence44
Exogenous drug-induced mouse models of atopic dermatitis44
TGF-β mediated drug resistance in solid cancer43
Current utilization of interferon alpha for the treatment of coronavirus disease 2019: A comprehensive review42
Suppressor of cytokine signaling 6 in cancer development and therapy: Deciphering its emerging and suppressive roles42
Immunosuppressive tumor microenvironment and uterine fibroids: Role in collagen synthesis42
Chemokines and chemokine receptors: Insights from human disease and experimental models of helminthiasis40
Principles of the activin receptor signaling pathway and its inhibition37
Scarless wound healing: Current insights from the perspectives of TGF-β, KGF-1, and KGF-237
The cGAS-STING pathway: Post-translational modifications and functional implications in diseases36
Neurotrophic factors and their receptors in lung development and implications in lung diseases35
Tumor microenvironment, histone modifications, and myeloid-derived suppressor cells35
Exosomes as a modulator of immune resistance in human cancers35
COVID-19 and dys-regulation of pulmonary endothelium: implications for vascular remodeling34
Multifaceted role of CD14 in innate immunity and tissue homeostasis34
MDSCs might be “Achilles heel” for eradicating CSCs33
Decoding the roles of heat shock proteins in liver cancer31
Exosomes: Another intercellular lipometabolic communication mediators in digestive system neoplasms?31
Editorial Board31
The IFN-γ/miniTrpRS signaling axis: An insight into the pathophysiology of osteoporosis and therapeutic potential31
B cell-activating factor and its targeted therapy in autoimmune diseases30
The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies30
Modulation of IL-33/ST2 signaling as a potential new therapeutic target for cardiovascular diseases29
Quantitative and qualitative differences in the activation of a fibroblast growth factor receptor by different FGF ligands29
Netrin-1: An emerging player in inflammatory diseases28
The roles of cell-cell and organ-organ crosstalk in the type 2 diabetes mellitus associated inflammatory microenvironment28
Nuclear translocation of RON receptor tyrosine kinase. New mechanistic and functional insights27
Crosstalk between ferroptosis and the epithelial-mesenchymal transition: Implications for inflammation and cancer therapy27
The impact of adipokines on vascular networks in adipose tissue27
Chemokine networks modulating natural killer cell trafficking to solid tumors26
Forgetting COVID-19 – Introduction to the special issue26
The role of Extracellular Vesicles in glycolytic and lipid metabolic reprogramming of cancer cells: Consequences for drug resistance25
Extracellular vesicles: Emerging mediators of cell communication in gastrointestinal cancers exhibiting metabolic abnormalities25
Liquid biopsy analysis of lipometabolic exosomes in pancreatic cancer24
Therapeutic inhibition of the JAK-STAT pathway in the treatment of inflammatory bowel disease24
Exosomal noncoding RNA-mediated spatiotemporal regulation of lipid metabolism: Implications in immune evasion and chronic inflammation24
mTOR in programmed cell death and its therapeutic implications23
Role of exosomes in transferring chemoresistance through modulation of cancer glycolytic cell metabolism23
Nefarious NTRK oncogenic fusions in pediatric sarcomas: Too many to Trk22
Cholecystokinin and gastrin as immune modulating hormones: Implications and applications22
Editorial Board22
ALCAM/CD166: A pleiotropic mediator of cell adhesion, stemness and cancer progression21
Glioblastoma-associated macrophages: A key target in overcoming glioblastoma therapeutic resistance21
The role and transformative potential of IL-19 in atherosclerosis20
Exosomes-regulated lipid metabolism in tumorigenesis and cancer progression20
Interleukin-17: A pleiotropic cytokine implicated in inflammatory, infectious, and malignant disorders20
Could IL-25 be a potential therapeutic target for intestinal inflammatory diseases?19
Uncovering key mechanisms and intervention therapies in aging skin19
JAK inhibitors in immune regulation and treatment of vitiligo18
Regulation of regulated cell death by extracellular vesicles in acute kidney injury and chronic kidney disease17
The IL-2A receptor pathway and its role in lymphocyte differentiation and function17
The journey of STING: Guiding immune signaling through membrane trafficking17
Alternative pathways driven by STING: From innate immunity to lipid metabolism17
The critical role of osteopontin (OPN) in fibrotic diseases16
The activin-follistatin system: Key regulator of kidney development, regeneration, inflammation, and fibrosis16
Cancer-associated fibroblasts: Vital suppressors of the immune response in the tumor microenvironment16
Crosstalk between lncRNAs in the apoptotic pathway and therapeutic targets in cancer16
Editorial Board16
Unraveling the intricacies of neutrophil extracellular traps in inflammatory bowel disease: Pathways, biomarkers, and promising therapies16
Retard or exacerbate: Role of long non-coding RNA growth arrest-specific 5 in the fibrosis16
Multiple post-translational modifications ensure EGFR functionality: Potential therapeutic targets to overcome its drug-resistance mutations16
Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: The straw that breaks the camel's back?15
The conundrum of current anti-SARS-CoV-2 vaccines15
The functional roles of m6A modification in T lymphocyte responses and autoimmune diseases15
Galectins as modulators of receptor tyrosine kinases signaling in health and disease15
The anti-inflammatory effects of itaconate and its derivatives in neurological disorders15
GLP-1R agonist therapy and vaccine response: Neglected implications14
Serum amyloid A and inflammasome activation: A link to breast cancer progression?14
LC3B: A microtubule-associated protein influences disease progression and prognosis14
Macrophage migration inhibitor factor (MIF): Potential role in cognitive impairment disorders14
FGF/FGFR signaling: From lung development to respiratory diseases13
Endothelial and macrophage interactions in the angiogenic niche13
Interleukin-33/serum stimulation-2 pathway: Regulatory mechanisms and emerging implications in immune and inflammatory diseases13
T cell receptor signaling in the differentiation and plasticity of CD4+ T cells13
Recent progress and prospects for anti-cytokine therapy in preclinical and clinical acute lung injury13
Decoding the neuroimmune axis in colorectal cancer: From neural circuitry to therapeutic innovation13
Hallmarks of aging and immunosenescence: Connecting the dots12
Cytokines on the way to secretion12
Cytokines and soluble mediators as architects of tumor microenvironment reprogramming in cancer therapy12
Pharmacological therapies and drug development targeting SARS-CoV-2 infection12
The impact of cytokines in neuroinflammation-mediated stroke12
Immune evasion of neutralizing antibodies by SARS-CoV-2 Omicron12
Exosome-mediated metabolic reprogramming: Implications in esophageal carcinoma progression and tumor microenvironment remodeling12
Revisiting IRF1-mediated antiviral innate immunity11
The interleukin-1 cytokine family members: Role in cancer pathogenesis and potential therapeutic applications in cancer immunotherapy11
SARS-CoV-2 infection and oxidative stress: Pathophysiological insight into thrombosis and therapeutic opportunities11
The Coronavirus pandemic – 2022: Viruses, variants & vaccines11
Role of lipid signalling in extracellular vesicles-mediated cell-to-cell communication11
Assessment of clinical studies evaluating combinations of immune checkpoint inhibitors with locoregional treatments in solid tumors11
The odyssey of cGAS: From cytosol to nucleus10
Molecular regulation of autophagy in a pro-inflammatory tumour microenvironment: New insight into the role of serum amyloid A10
Unveiling the role of IL-17: Therapeutic insights and cardiovascular implications10
The role of microglial activation on ischemic stroke: Modulation by fibroblast growth factors10
Extracellular vesicles as mediators of cell-cell communication in ovarian cancer and beyond – A lipids focus10
Targeting interleukin-17 in radiation-induced toxicity and cancer progression10
The involvement of TH17 cells in the pathogenesis of IBD10
Glycosylation of FGF/FGFR: An underrated sweet code regulating cellular signaling programs10
Preexisting immunity: Barrier or bridge to effective oncolytic virus therapy?9
Mechanisms of NLRP3 inflammasome activation and the development of peptide inhibitors9
0.045873165130615